Concepedia

Philip A. Iredale

PA

Statistics

Publications

26

Citations

1.3K

H-Index

19

Active since

1992

Affiliations

Pfizer (United States)(Current)

Yale University

Queen's Medical Centre

Connecticut Mental Health Center

Virginia Commonwealth University

Philip A. Iredale is an author at Pfizer (United States) specializing in medicine, social sciences, and neuroscience.

Top concepts

Publications per year

1992–2012

26

Publications

26

Increases in intracellular calcium via activation of an endogenous P<sub>2</sub>‐purinoceptor in cultured CHO‐K1 cells

Philip A. Iredale, Stephen J. Hill · British Journal of Pharmacology · 1993 · 139 citations · Full text

CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity

Judith A. Siuciak, Douglas S. Chapin, Sheryl A. McCarthy et al. · Neuropharmacology · 2006 · 131 citations

, , +11

Discovery of Two Clinical Histamine H <sub>3</sub> Receptor Antagonists: <i>trans</i> - <i>N</i> -Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and <i>trans</i> -3-Fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]- <i>N</i> -(2-methylpropyl)cyclobutanecarboxamide (PF-03654764)

Travis T. Wager, Betty Pettersen, Anne W. Schmidt et al. · Journal of Medicinal Chemistry · 2011 · 107 citations · Full text

Blockade of Cannabinoid Type 1 Receptors Augments the Antiparkinsonian Action of Levodopa without Affecting Dyskinesias in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Rhesus Monkeys

Xuebing Cao, Liang Li, John R. Hadcock et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 101 citations

Role of Corticotropin‐Releasing Factor Receptor‐1 in Opiate Withdrawal

Philip A. Iredale, John D. Alvaro, Young-Lim Lee et al. · Journal of Neurochemistry · 2000 · 98 citations · Full text

1–5 of 26